Compare Starter Doses: Wegovy vs Mounjaro Mechanisms
Understanding Mounjaro or Wegovy Which Is Better for Starter Treatment
When considering Mounjaro or Wegovy which is better for beginning your weight management journey, the key difference lies in their mechanisms and starter dose approaches. Wegovy begins with a 0.25mg dose for weeks 1-4, using semaglutide to target GLP-1 receptors exclusively. Mounjaro starts at 2.5mg, employing tirzepatide's dual-action approach targeting both GIP and GLP-1 receptors simultaneously.
The starter dose phase is crucial for both medications, allowing your body to adjust gradually whilst minimising potential side effects like nausea. Wegovy's 16-week dose escalation follows a structured path: 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance. Mounjaro follows its own escalation schedule, increasing every four weeks to reach its maintenance doses. Both treatments require prescription-only medicine status and must be used alongside a reduced-calorie diet and increased physical activity.
Pricing Comparison: Starter Dose Costs and Value
At EverydayMeds, Wegovy's 0.25mg starter dose costs £79.99 for new customers using code FIRST40 at checkout. Our Intro Duo bundle (0.25mg and 0.5mg pens) provides your first two months for £169.99, offering convenient supply continuity. Mounjaro pricing follows a different structure due to its distinct dosing regimen and dual-receptor mechanism.
For those questioning Mounjaro or Wegovy which is better value during the starter phase, consider that Wegovy's gentler dose escalation may suit patients who prefer a more gradual introduction to GLP-1 therapy. Our GPhC-registered pharmacy (#9012878) offers both options with transparent pricing and no hidden fees. Returning customers benefit from code DOSE25 at checkout, and all orders include next-day cold-chain delivery once prescribed.
Clinical Evidence: Mounjaro or Wegovy Which Is Better Supported
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). STEP 5 showed sustained results of approximately clinically studied weight loss at 2 years, whilst the SELECT trial revealed a 20% reduction in major cardiovascular events.
Mounjaro's clinical evidence comes from different trial populations and endpoints, making direct weight loss percentage comparisons inappropriate. Both medications have demonstrated efficacy in their respective clinical programmes, and when considering Mounjaro or Wegovy which is better, your prescriber will evaluate your individual health profile, medical history, and treatment goals to make the most appropriate recommendation.
How Wegovy Works: GLP-1 Starter Dose Mechanism
Wegovy's 0.25mg starter dose introduces semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. This mechanism works primarily on brain appetite centres, reducing hunger signals and promoting satiety after smaller meals. The starter dose allows your digestive system to adapt gradually, as GLP-1 receptors are found throughout your gastrointestinal tract. Many patients notice reduced food cravings and earlier feelings of fullness during the initial 0.25mg phase. The gentle introduction helps minimise common side effects whilst establishing the foundation for your weight management journey.
Ordering Process: Getting Your Starter Dose
Beginning your journey starts with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service) to determine whether Mounjaro or Wegovy which is better suits your needs. Once prescribed, your starter dose ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. All orders include comprehensive dosing instructions, injection technique guidance, and ongoing support from our clinical team. The entire process ensures you receive genuine, licensed medication safely and legally.
Storage and Practical Considerations for Starter Treatment
Wegovy offers a significant storage advantage, remaining stable for up to 6 weeks at room temperature below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design makes weekly injections straightforward, with clear dose windows and safety features. Your 0.25mg starter dose must be stored at 2-8°C before first use, and you cannot skip doses or accelerate the escalation schedule for safety reasons. The prescribed dose escalation timeline ensures optimal tolerance whilst building therapeutic effectiveness. This storage flexibility particularly benefits travellers or those with varying schedules.
Starter Dose Tolerance: Mounjaro or Wegovy Which Is Better Tolerated
Individual tolerance varies significantly between patients, making the question of Mounjaro or Wegovy which is better highly personalised. Wegovy's 0.25mg starter dose provides a gentle introduction to GLP-1 therapy, with most patients experiencing mild, transient nausea that typically improves within the first few weeks. Eating smaller meals, avoiding fatty foods, and injecting at consistent times can enhance tolerance during the starter phase.
Mounjaro's dual-receptor mechanism affects both GIP and GLP-1 pathways, potentially offering different side effect profiles compared to Wegovy's single-pathway approach. Some patients may tolerate one mechanism better than another, which is why prescriber guidance proves essential. Both medications require gradual dose escalation to optimise tolerance and effectiveness, and neither should be considered superior without individual clinical context.
Making Your Choice: Expert Prescriber Guidance Available
When deciding Mounjaro or Wegovy which is better for your starter treatment, multiple factors influence the decision beyond just the medications themselves. Your medical history, concurrent medications, lifestyle factors, and personal preferences all play crucial roles in treatment selection. Our qualified prescribers evaluate these factors comprehensively during the clinical assessment process, ensuring your chosen treatment aligns with your health profile and goals. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you. The decision ultimately depends on your individual circumstances rather than one treatment being universally superior to another.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
